<ѻýҕl>New Oral Drug Approved for Metastatic Colorectal Cancerѻýҕl> In phase III trials of pretreated patients, fruquintinib improved survival versus placebo Nov 09, 2023
<ѻýҕl>Personalized Intervention Helps CRC Screening Decisions for Older Adultsѻýҕl> Patients receiving intervention were less likely to undergo screening if benefits were low Oct 31, 2023
<ѻýҕl>Chinese Compound for MI?; Knee Pain Managementѻýҕl> Also in TTHealthWatch: a new colorectal cancer screening test Oct 28, 2023 podcast
<ѻýҕl>Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FITѻýҕl> ColoSense test outperforms fecal immunochemical testing in phase III trial Oct 25, 2023
<ѻýҕl>Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancerѻýҕl> Standard dose of sotorasib plus panitumumab reduced risk of progression by 51% vs standard care Oct 23, 2023
<ѻýҕl>Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Resultsѻýҕl> Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
<ѻýҕl>Cancer Risk in NAFLD Higher With Early Disease Onsetѻýҕl> 52% greater risk of malignancy for patients diagnosed with fatty liver disease before age 45 Sep 27, 2023
<ѻýҕl>When Screening Guidelines Collide, Who Wins?ѻýҕl> A closer look at conflicting colorectal cancer screening recommendations Sep 26, 2023
<ѻýҕl>Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancerѻýҕl> Threefold risk reduction with enoxaparin in high-risk gastrointestinal, lung cancers Sep 21, 2023
<ѻýҕl>Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC?ѻýҕl> Strategy tied to better outcomes but fails to meet primary goal of phase II trial Sep 18, 2023
<ѻýҕl>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enoughѻýҕl> Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<ѻýҕl>Study Links Being Breastfed to Cancer Risk in Adulthoodѻýҕl> But researchers say the established benefits likely outweigh any potential risk Sep 08, 2023
<ѻýҕl>AI-Aided Colonoscopy Flops for Advanced Neoplasia Detection in Trialѻýҕl> Meta-analysis turns up similar findings, though increased ADR overall Aug 28, 2023
<ѻýҕl>Does Cancer Screening Actually Extend Lives?ѻýҕl> A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
<ѻýҕl>Novel KRAS Inhibitor Leads to Durable Responses in Multiple Tumor Typesѻýҕl> More than half of patients with NSCLC, more than a third of those with CRC responded to divarasib Aug 23, 2023
<ѻýҕl>ACP Sticks With Age 50 for Colorectal Cancer Screeningѻýҕl> Guidance conflicts with other new recommendations that screening start at age 45 Aug 01, 2023
<ѻýҕl>Multi-Cancer Early Detection: 20th-Century Fiction Becomes Realityѻýҕl> These tests could soon become a valuable addition to current cancer screening tools Aug 01, 2023
<ѻýҕl>Age No Barrier to Preserved QoL, Functional Recovery After Surgery for CRCѻýҕl> More than 70% of patients with a median age of 79 achieved both outcomes at 3-6 months Jul 13, 2023
<ѻýҕl>Omitting RT Safe in Many Locally Advanced Rectal Cancersѻýҕl> Most intermediate-risk cases can be cured without pelvic radiation, says investigator Jun 05, 2023
<ѻýҕl>UnitedHealthcare in the Hot Seat Over GI Procedure 'Advance Notification' Policyѻýҕl> New rule came in response to concerns over proposed prior authorization policy Jun 01, 2023
<ѻýҕl>Medicaid Expansion Tied to Better Outcomes in Black Patients With GI Cancersѻýҕl> Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states May 25, 2023
<ѻýҕl>Warning: Prior Auth for Colonoscopy Is the Wrong Way to Goѻýҕl> The policy adds delays to care and may worsen health outcomes May 24, 2023
<ѻýҕl>Anti-EGFR Rechallenge Boosts PFS in Third-Line Metastatic Colorectal Cancerѻýҕl> ctDNA-identified wild-type tumors benefited most from adding panitumumab to standard therapy May 23, 2023
<ѻýҕl>AI in Colonoscopy: Disconnect Grows Between Academic, Community Studiesѻýҕl> Clearly helpful in manufacturers' trials, but not so much in routine practice May 09, 2023
<ѻýҕl>Study: VA Surgeons Who Do Colonoscopies May Need More Trainingѻýҕl> Outdone by gastroenterologists in finding adenomatous polyps May 08, 2023
<ѻýҕl>Medicaid Expansion Seen Lifting Colon Cancer Screening for Low-Income Peopleѻýҕl> But not a cure-all in states boosting eligibility May 06, 2023
<ѻýҕl>HIPEC With Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon Cancerѻýҕl> No increase in adverse events or toxicity versus surgery alone Apr 26, 2023
<ѻýҕl>Genomics Add Insight Into Worse Colorectal Cancer Outcomes in Black Patientsѻýҕl> Fewer actionable mutations, less likely to meet genomic criteria for immunotherapy Apr 19, 2023
<ѻýҕl>Many With Cancer Predisposition Diseases Unaware of Genetic Statusѻýҕl> Moreover, a significant proportion do not qualify for genetic screening under current guidelines Apr 19, 2023
<ѻýҕl>Does Your 80-Year-Old Patient Really Need That Colonoscopy?ѻýҕl> Physicians often ignore life expectancy in screening decisions, study finds Apr 04, 2023
<ѻýҕl>Take Risk Into Account Before Repeat Surveillance Colonoscopy, Study Saysѻýҕl> 58% of seniors with limited life expectancy, no significant findings invited for another round Mar 14, 2023
<ѻýҕl>KRAS Mutations in Metastatic CRC Predict Survival Benefit of Chemo Comboѻýҕl> Trifluridine/tipiracil fails to improve survival in patients with KRAS G12-mutant tumors Mar 06, 2023
<ѻýҕl>'Alarming' Rise in Colon Cancer Rates Among Younger Peopleѻýҕl> Rate doubled in under-50 age group since 1995, concerning trend toward more advanced disease Mar 01, 2023
<ѻýҕl>FDA Has Concerns on 'Unprecedented' Plan for Dostarlimab in Rectal Cancerѻýҕl> Panel will discuss if single-arm trials and proposed endpoints are adequate to support approval Feb 08, 2023
<ѻýҕl>Patients' Defensive Thinking May Hinder Colorectal Cancer Screeningѻýҕl> Study explored why people refused at-home stool test Feb 06, 2023
<ѻýҕl>Neoadjuvant Chemo Reduces Disease Recurrence in Operable Colon Cancerѻýҕl> Consider it now "an option" for locally advanced disease, editorialists say Jan 24, 2023
<ѻýҕl>New Standard of Care for Refractory Metastatic Colorectal Cancerѻýҕl> Significant improvement in OS, PFS with addition of bevacizumab to trifluridine/tipiracil Jan 23, 2023
<ѻýҕl>We're Underutilizing Genetic Testing for Colorectal Cancerѻýҕl> Universal germline testing should be part of the standard of cancer care Jan 20, 2023
<ѻýҕl>Circulating Tumor DNA Could Guide Use of Chemo in Colorectal Cancerѻýҕl> Identified patients likely to benefit following surgery, large prospective study showed Jan 19, 2023
<ѻýҕl>Adagrasib Shows Anti-Tumor Activity in Heavily Pretreated KRAS-Mutant CRCѻýҕl> Response rates of 19% alone, 46% with cetuximab in phase I/II trial Dec 21, 2022